Skip to content
Back to Guavy Wire
Stocks

Goldman Sachs Sticks to Buy Rating on J&J with $282 Target Price

Instruments
JNJ
Share

Goldman Sachs analyst Asad Haider has maintained his 'buy' rating on Johnson & Johnson (JNJ.US), keeping the target price at $282. This recommendation is based on Haider's impressive track record, with an 84.3% success rate and a total average return of 22.6% over the past year.

TipRanks data shows that Haider has consistently delivered strong results, earning a 4-star rating from the platform. This indicates that his recommendations have generated a positive return for TipRanks' virtual portfolio over the past year.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc